| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000036916 |
| Receipt No. | R000042069 |
| Scientific Title | The test of effect on stress reduction by using higher humidity and lower temperature sauna. |
| Date of disclosure of the study information | 2019/06/03 |
| Last modified on | 2019/09/01 (Ver. 2) |
| Basic information | ||
| Public title | The test of effect on stress reduction | |
| Acronym | The test of effect on stress reduction | |
| Scientific Title | The test of effect on stress reduction by using higher humidity and lower temperature sauna. | |
| Scientific Title:Acronym | The test of effect on stress reduction by using higher humidity and lower temperature sauna. | |
| Region |
|
|
| Condition | |||
| Condition | Not applicable | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To prove benefits of a higher humidity and lower temperature sauna on stress reduction. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Salivary cortisol, salivary IgA, salivary oxytocin |
| Key secondary outcomes | Salivary amylase, Salivary chromogranin, Skin moisture level, Blood pressure, Body temperature, Body weight, The incidence of side effects and/or adverse events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Using a higher humidity and lower temperature sauna at first visit. After rest period, using a higher temperature sauna at second visit.
|
|
| Interventions/Control_2 | Using a higher temperature sauna at first visit. After rest period, using a higher humidity and lower temperature sauna at second visit. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1)Males aged 40 to 59 at registration.
2) Subjects who has systolic blood pressure less than 159 mmHg or diastolic blood pressure less than 99 mmHg in blood pressure measurement at pre-test 3) Subjects who are usually aware of a certain level of stress 4) Subjects giving written informed consent. |
|||
| Key exclusion criteria | 1) Subjects who have been diagnosed with a mental disorder such as depression in the past, or are currently undergoing treatment.
2) Subjects who are continuing treatment with medicine. 3) Subjects who feels extremely frustrated and has trouble with everyday life. 4) Subjects who is aware that it is easy to dry in the mouth or little salivation. 5) Subjects who are claustrophobic and can not enter the sauna room. 6) Subjects who difficult to sweat in sauna bath. 7) Subjects who have tattoo. 8) Subjects who have wide barns scar. 9) Subjects with bruises, scratches, or acne on their cheeks. 10) Subjects who is severely sunburned or who works or plays sports outdoors for a long time. 11) Subjects who have special care on the face skin or arm skin (facial esthetics, body esthetics, facial care, peeling, laser treatment, hair removal etc.). 12) Subjects who plan to travel abroad or s wimming bath in the test period 13) Subjects who constantly use medicines, supplements having a possibility of affecting test results. 14) Subjects who have a history of and/or a history of serious illness in the heart, liver, kidney, digestive tract etc. 15) Subjects who excessive alcohol intake. 16) Subjects who have extremely irregular dining habits, and subjects who have midnight work or irregular shift work. 17) Subjects who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. 18) Others who have been determined ineligible by principal investigator or sub-investigator. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | SHIODA Life Science Inc. | ||||||
| Division name | President | ||||||
| Zip code | 106-0031 | ||||||
| Address | Sunrise Roppongi 3B, 3-2-9 Nishiazabu, Minato-ku, Tokyo, Japan | ||||||
| TEL | 03-6804-5371 | ||||||
| shioda@hoshi.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | CPCC Company Limited | ||||||
| Division name | Planning & Sales Department | ||||||
| Zip code | 101-0047 | ||||||
| Address | 4F Sanwauchikannda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN | ||||||
| TEL | 03-5927-3112 | ||||||
| Homepage URL | |||||||
| cpcc-contact@cpcc.co.jp | |||||||
| Sponsor | |
| Institute | CPCC Company Limited |
| Institute | |
| Department | |
| Funding Source | |
| Organization | SHIODA Life Science Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Chiyoda Paramedical Care Clinic |
| Address | 2F Sanwauchikannda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN |
| Tel | 3-5297-5548 |
| IRB@cpcc.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000042069 |